substantially higher risk of nonalcoholic fatty liver disease, as defined by a fatty liver index of ≥60 (ref.21) or a hepatic steatosis index of >36 (ref.22), compared to noncarriers (OR = 3.73 (2.26−6.16),P= 8.4 × 10−7, 45% case prevalence). BSNcarrier status m...